Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 1.00 |
| ▸ | CDK1 | P06493 | 13/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 9/20 | 0.47 |
| ▸ | CCNB2 | O95067 | 8/20 | 0.47 |
| ▸ | CCNB3 | Q8WWL7 | 8/20 | 0.47 |
| ▸ | CDK2 | P24941 | 6/20 | 0.45 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.45 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.45 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.45 |
| ▸ | CCNK | O75909 | 1/20 | 0.44 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 6/20 | 0.42 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.42 |
| ▸ | CLK2 | P49760 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2314094 | 1.00 | AHR (1.00) | AHRCDK1CCNB1CCNB2CCNB3 | |
| Hydrochloric Acid SCHEMBL15422822 | 0.99 | AHR (0.98) | AHRCDK1CCNB1CCNB2CCNB3 | |
| Hydrochloric Acid SCHEMBL31615007 | 0.99 | AHR (0.98) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL2315208 | 0.93 | AHR (0.87) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL15011335 | 0.93 | AHR (0.87) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL2317306 | 0.92 | AHR (0.85) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL19766270 | 0.92 | AHR (0.85) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL2311353 | 0.91 | AHR (0.84) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL2315457 | 0.91 | AHR (0.83) | AHRCDK1CCNB1CCNB2CCNB3 | |
| SCHEMBL2314087 | 0.91 | AHR (0.83) | AHRCDK1CCNB1CCNB2CCNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024849-A1 | COMPOSITIONS AND METHODS OF MAKING AND USING IPSC-DERIVED CAR MACROPHAGES | CITY OF HOPE (US) | 2025-01-30 | — | — | WO | claimed |
| CN-110546262-B | Compositions and methods for treating hemoglobinopathies | 诺华股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| EP-3362075-B1 | NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF | CELULARITY INC (US) | 2023-06-07 | — | — | EP | claimed |
| CN-115176005-A | Compositions and methods for treating hemoglobinopathies | 诺华股份有限公司 | 2022-10-11 | — | — | CN | claimed |
| EP-4743096-A1 | BIOBANK OF CELLULAR BANKS HAVING SPECIFIC HOMOZYGOUS HLA HAPLOTYPES AND USES THEREOF FOR TREATING PATIENTS | Meiragtx Cell Therapies (FR) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025199576-A1 | HAEMATOPOIETIC STEM/PROGENITOR CELLS AND METHODS FOR THEIR PRODUCTION | MURDOCH CHILDREN'S RESEARCH INSTITUTE (AU) | 2025-10-02 | — | — | WO | disclosed |
| US-20250043311-A1 | MICROSPHERE FACILITATED INTRACELLULAR DELIVERY AND ASSOCIATED METHODS AND DEVICES | VisiCELL Medical Inc. (US) | 2025-02-06 | — | — | US | disclosed |
| WO-2025024849-A1 | COMPOSITIONS AND METHODS OF MAKING AND USING IPSC-DERIVED CAR MACROPHAGES | CITY OF HOPE (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2025012449-A1 | BIOBANK OF CELLULAR BANKS HAVING SPECIFIC HOMOZYGOUS HLA HAPLOTYPES AND USES THEREOF FOR TREATING PATIENTS | SMART IMMUNE (FR) | 2025-01-16 | — | — | WO | disclosed |
| CN-119286853-A | Compositions and methods for treating hemoglobinopathies | 诺华股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119193710-A | Reduced and minimal manipulation of genetically modified cells | 弗莱德哈钦森癌症中心 | 2024-12-27 | — | — | CN | disclosed |
| US-12173320-B2 | Production of red blood cells and platelets from stem cells | BOSTON MEDICAL CENTER CORPORATION (US) | 2024-12-24 | — | — | US | disclosed |
| EP-3362075-B1 | NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF | CELULARITY INC (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-3524604-B1 | EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE | NOVARTIS AG (CH) | 2023-03-29 | — | — | EP | disclosed |
| WO-2023034941-A1 | MICROSPHERE FACILITATED INTRACELLULAR DELIVERY AND ASSOCIATED METHODS AND DEVICES | VisiCELL Medical Inc. (US) | 2023-03-09 | — | — | WO | disclosed |
| WO-2022269518-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | NOVARTIS AG (CH) | 2022-12-29 | — | — | WO | disclosed |
| EP-4096688-A1 | NATURAL KILLER CELLS FOR TREATMENT OF CORONAVIRUS INFECTION | Sorrento Therapeutics, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-4077676-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | Novartis AG (CH) | 2022-10-26 | — | — | EP | disclosed |
| CN-115176005-A | Compositions and methods for treating hemoglobinopathies | 诺华股份有限公司 | 2022-10-11 | — | — | CN | disclosed |
| US-20220177845-A1 | PRODUCTION OF RED BLOOD CELLS AND PLATELETS FROM STEM CELLS | BOSTON MEDICAL CENTER CORPORATION | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12173320-B2 | Production of red blood cells and platelets from stem cells | AHR, CD14, MPL | AHR 1/4885CDK1 3533/4885CCNB1 3834/4885 |
| US-20220177845-A1 | PRODUCTION OF RED BLOOD CELLS AND PLATELETS FROM STEM CELLS | AHR, CD14, MPL | AHR 1/4885CDK1 3533/4885CCNB1 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.